文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

立体定向放疗时代黑色素瘤脑转移预后指数是否仍然有效?

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
PubMed 文献 · Radiat Oncol · 2018-01-10

该回顾性分析纳入2004至2014年间接受立体定向放疗(SRT)且未接受过手术或全脑放疗的80例恶性黑色素瘤脑转移患者,共177个转移灶。中位生存期7.06个月;GGS、GPA和DS-GPA为显著生存预测因素,RADES无统计学意义;Karnofsky指数较高、单个脑转移灶和非结节型黑色素瘤组织学为生存正向预测因素。

要点

  • melanoma脑转移SRT后中位生存7.06个月,GGS、GPA和DS-GPA可预测生存。
  • DS-GPA的P值最优,但两个中危亚组间区分不足。
  • RADES无统计学显著预后价值;组织学亚型可能提升未来指数价值。

核心结论

  • 现有主要源于全脑放疗时代的预后评分不完全适用于接受SRT的黑色素瘤脑转移患者。
  • 黑色素瘤组织学亚型可能为未来专用预后指数增加价值。

研究设计与样本

  • 回顾性分析80例恶性黑色素瘤患者,接受SRT治疗颅内转移且此前未接受手术或全脑放疗,时间跨度为2004至2014年。
  • 共照射177个脑转移灶;采用单因素和多因素分析潜在预后因素,并用log-rank检验评估GPA、DS-GPA、GGS和RADES。

主要发现

  • 从放疗起算的中位生存时间为7.06个月。
  • GGS、GPA和DS-GPA为总体生存的显著预测因素。
  • DS-GPA的P值最优,但两个中危亚组间未显示充分区分。
  • RADES未显示任何统计学显著的预后价值。
  • 单因素和多因素分析中,较高的Karnofsky指数、单个脑转移灶和非结节型黑色素瘤组织学为生存的正向预测因素。

关键数值与推荐

  • GGS、GPA和DS-GPA经log-rank分析为显著生存预测因素。
  • DS-GPA在中间风险两个亚组间区分不足。
  • RADES无统计学显著预后价值。

临床怎么用

  • 对接受SRT的黑色素瘤脑转移患者,现有预后指数(GPA、DS-GPA、GGS)可参考但需注意其区分能力有限。
  • 评估预后时应结合Karnofsky指数、脑转移灶数目和黑色素瘤组织学亚型。

局限性

  • 回顾性分析,样本量为80例患者和177个转移灶。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Malignant melanoma brain metastases (MBM) are the third most common cause for brain metastases (BM). Historically Whole-brain radiotherapy (WBRT) was considered the goldstandard of treatment even though melanoma cells are regarded as very radioresistant. Therapeutic possibilities have fundamentally changed since the availability of stereotactic radiotherapy (SRT), where it is possible to apply high ablative doses in a very precise manner. In this work we analyze prognostic factors of overall survival (OS) after SRT in patients with MBM and evaluate the applicability of popular prognostic indices that mainly stem from the WBRT-era. MATERIALS AND METHODS: This work is a retrospective analysis of OS of 80 malignant melanoma (MM) patients who received SRT for intracranial melanoma metastases between 2004 and 2014 who had not received prior treatment for MBM in terms of surgery or WBRT. Potential prognostic factors were analyzed using univariable and multivariable analysis. Existing prognostic scores [Graded Prognostic Assessment (GPA), Diagnosis-Specific-GPA (DS-GPA), Golden Grading System (GGS) and RADES] were calculated and tested using log-rank analysis. RESULTS: Eighty patients, respectively 177 brain metastases, were irradiated. The median survival time from radiation was 7.06 months. Overall, GGS, GPA and DS-GPA were significant predictors of survival. The MM-specific index DS-GPA showed the best p-value but did not show adequate division when looking at the two intermediate risk subgroups. RADES did not show any statistically significant prognostic value. In univariable as well as in multivariable analyses a higher Karnofsky-Index, a single BM, and non nodular melanoma (NM) histology were positive predictors of survival. CONCLUSION: The existing prognostic scores do not seem to ideally fit for this special group of patients. Our results indicate that the histologic subtype of MM could add to the prognostic value of specialized future indices.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Badakhshi H, Engeling F, Budach V, et al. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era? Radiat Oncol. 2018. PMID: 29316943. doi:10.1186/s13014-017-0951-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。